Article PDF
References
The Heart Outcomes Prevention Evaluation Study investigators. Effects of an angiotensin-onverting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145–53.
The Heart Outcomes Prevention Evaluation (HOPE) Study investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus; results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253–9.
Chaturvedi N, Sjolie AK, Stephenson JM et al. Effect of lisinopril on progression of retinopathy in people with type diabetes. Lancet 1998;351:28–31.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barnett, A. The Heart Outcomes Protection Evaluation (HOPE) study: relevance to ophthalmological practice?. Eye 14, 1–2 (2000). https://doi.org/10.1038/eye.2000.1
Issue Date:
DOI: https://doi.org/10.1038/eye.2000.1
This article is cited by
-
Medical treatment of diabetic retinopathy
Eye (2003)